Richmond, Virginia, April 11, 2013 — avVaa World Health Care Products’ (“the Company”) (Pink Sheets: AVVH) announces that it has filed its annual financial statements for the year ended May 31, 2011 and for the year ended May 31, 2012. In addition to the annual financials, the company has also filed quarterly interim financials for the first quarter ended on August 31, 2012 & second quarter ended on November 30, 2012.
Fiscal year 2012 Summary
For the fiscal year ending May 31, 2012 the company has increased gross profits by over 350% and reduced operating expenses by almost 800%. “avVaa has made tremendous improvements in reducing costs while increasing gross profits,” said Jason Price, CEO of avVaa. “I am really proud how far we have come and even more excited about the future of avVaa. This is just another small step in adding value for our shareholders.”
About avVaa World Health Care Products
avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin® line of skin care products through mass food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com .
Jason Price Chairman & CEO
avVaa World Health Care Products
P: 1-866-864-6598
E: jason.price@avvaa.com www.avvaa.com
Pink Sheets: AVVH
Safe Harbor
This news release contains statements which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of avVaa World Health Care Products, and members of its management, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.
